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ABSTRACT Herpes simplex virus (HSV) utilizes and subverts host chromatin mechanisms to express its lytic gene products in
mammalian cells. The host cell attempts to silence the incoming viral genome by epigenetic mechanisms, but the viral VP16 and
ICP0 proteins promote active chromatin on the viral genome by recruiting other host epigenetic factors. However, the depen-
dence on VP16 and ICP0 differs in different cell lines, implying cell type-dependent functional contributions of epigenetic fac-
tors for HSV gene expression. In this study, we performed a targeted RNA interference (RNAi) screen for cellular chromatin fac-
tors that are involved in regulation of herpes simplex virus (HSV) gene expression in U2OS osteosarcoma cells, a cell line that
complements ICP0mutant and VP16mutant virus replication. In this screen, we found the same general classes of chromatin
factors that regulate HSV gene expression in U2OS cells as in other cell types, including histone demethylases (HDMs), histone
deacetylases (HDACs), histone acetyltransferases (HATs), and chromatin-remodeling factors, but the specific factors within
these classes are different from those identified previously for other cell types. For example, KDM3A and KDM1A (LSD1) both
demethylate mono- and dimethylated H3K9, but KDM3A emerged in our screen of U2OS cells. Further, small interfering RNA
(siRNA) and inhibitor studies support the idea that KDM1A is more critical in HeLa cells, as observed previously, while KDM3A
is more critical in U2OS cells. These results argue that different cellular chromatin factors are critical in different cell lines to
carry out the positive and negative epigenetic effects exerted on the HSV genome.
IMPORTANCE Upon entry into the host cell nucleus, the herpes simplex virus genome is subjected to host epigenetic silencing
mechanisms. Viral proteins recruit cellular epigenetic activator proteins to reverse and counter the cellular silencing mecha-
nisms. Some of the host silencing and activator functions involved in HSV gene expression have been identified, but there have
been indications that the host cell factors may vary in different cell types. In this study, we performed a screen of chromatin fac-
tors involved in HSV gene regulation in osteosarcoma cells, and we found that the chromatin factors that are critical for HSV
gene expression in these cells are different from those for previously studied cell types. These results argue that the specific chro-
matin factors operative in different cell lines and cell types may differ. This has implications for epigenetic drugs that are under
development.
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Nuclear DNA viruses encode gene products that inhibit hostepigenetic silencing factors and recruit host activating epige-
netic factors to provide active euchromatin for transcription of
their genes (1). Herpes simplex virus (HSV) virion DNA is not
associated with histones but is rapidly chromatinized upon entry
into the nuclei of cells (2, 3). Viral gene products are involved in
the blocking and/or removal of repressive chromatin (3–5). Ex-
pression of viral immediate-early (IE) genes is dependent on the
virion protein VP16, which forms an activator complex contain-
ing the cellular host cell factor 1 (HCF-1) and octamer-binding
protein 1 (Oct-1). Oct-1 binds to sites in IE gene promoters, and
HCF-1 recruits transcription factors and chromatin-modifying
factors that promote IE gene transcription (5–7). The HCF-1 sub-
unit recruits several chromatin-modifying enzymes, including (i)
the KMT2F (SETD1A) histone H3 lysine 4 (H3K4) methyltrans-
ferase (8), which introduces the histone H3K4 trimethylation eu-
chromatin mark, (ii) the KDM1A (LSD1) demethylase (9), which
removes the H3K9me1/2 heterochromatin mark, and (iii) the
KDM4 (JMJD2) demethylase (10), which removes the H3K9me3
heterochromatin mark. Efficient expression of the IE genes, espe-
cially ICP0, is also dependent on the SNF2H chromatin remodel-
ing subunit (11), but the mechanism of its recruitment to IE genes
is not known. These and other chromatin modifications allow the
transcription of the viral IE genes. The IE protein ICP0 then in-
hibits chromatin-silencing mechanisms on the entire genome, at
least in part by inhibition of CoREST-HDAC1 complexes (12) and
by recruitment of the CLOCK histone acetyltransferase (HAT)
enzyme (13).
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HSV strains that fail to encode VP16 or ICP0 proteins or that
encode defective forms of them show defects in gene expression
and replication, but the levels of the defects vary in different cell
lines (14–16). Also, depletion of activator complex-interacting
proteins, such as the histone acetyltransferases p300, CBP, PCAF,
and GCN5 or the chromatin remodeling factors BRM and Brg-1,
does not result in significant defects in viral gene expression (6).
Epigenetic inhibitors have also shown cell type-dependent effects
on the HSV life cycle. Treatment with HDAC inhibitors reacti-
vates latently infected HSV in certain cell types (17–19). Interest-
ingly, KDM1A (LSD1) preferentially demethylates the euchro-
matic marks H3K4me1/2 when associated with RCOR1/CoREST
but demethylates the heterochromatic marks H3K9me1/2 when
associated with the androgen receptor, which functions as a core-
pressor or coactivator (9, 20–22). Another type of HDM, KDM3A,
is known to target H3K9me1/2 but not H3K4me1/2 (23). How-
ever, the mechanisms by which these redundant KDMs select a
given substrate are not understood. It is possible that certain sub-
sets of histone-modifying enzymes are functionally more active in
different complexes, which could be cell type dependent and/or
signal transduction pathway dependent.
We hypothesized that different subsets of chromatin-
modifying factors are functionally more active for HSV infection
in specific cell lines. In this study, we used U2OS osteosarcoma
cells because they are known to complement the growth defect of
HSV-1 ICP0-negative mutant viruses (14) and in particular to
complement the epigenetic phenotypes of ICP0-negative mutant
viruses observed in other cell types (3, 24). U2OS cells are also
known to partially complement the growth defect of HSV-1 VP16
mutant viruses (15). Therefore, we speculated that U2OS cells
might contain a set of epigenetic factors required for regulation of
HSV gene expression different from those in cells that require
ICP0 and/or VP16 for HSV infection. To investigate this question,
we performed a screen to identify chromatin-modifying genes
that contribute to HSV gene expression in U2OS cells. RNA inter-
ference (RNAi) was used to suppress each candidate gene, and an
imaging readout was used to assess viral gene expression from an
HSV recombinant virus, HSV8GFP, in which an essential viral
protein, ICP8, is fused to green fluorescent protein (GFP). We
found that the previously documented general classes of chroma-
tin factors are also required in U2OS cells but that the specific
members of these classes are different.
RESULTS
Establishment of an HSV infection screening system. Different
cell lines show differential restriction of HSV ICP0-negative re-
combinant strains (14). For example, U2OS cells are known to
complement the growth defect of HSV-1 ICP0-negative mutant
viruses (14) and VP16 mutant viruses (15) and in particular to
complement the altered viral chromatin phenotype of ICP0-
negative mutant viruses observed in other cell types (3, 24). Po-
tential altered epigenetic regulatory mechanisms are that U2OS
cells are known to not express ATRX (25), and the IFI16 nuclear
DNA sensor does not respond to HSV infection (26, 27). There-
fore, we speculated that the set of epigenetic factors involved in
regulating HSV gene expression in U2OS cells might differ from
those in other cell types previously studied (1). We therefore con-
ducted a targeted small interfering RNA (siRNA) screen of host
chromatin factors functioning in U2OS cells to regulate HSV gene
expression.
We first defined the viral gene products that regulate HSV gene
expression in U2OS cells used for the screen by measuring viral
ICP8 (UL29) gene expression in cells infected with different viral
mutant strains. Infected cell protein 8 (ICP8) is an early gene
product, and therefore this screen would identify factors that are
important for regulating stages of the productive HSV life cycle,
including immediate-early and early gene expression, and the
transition to late gene expression. To test the role of VP16, which
is required for optimal IE gene expression (16), we infected U2OS
cells with a VP16 mutant virus, in1814, or the rescued virus strain
in1814R. We observed that at 8 hours postinfection (hpi) in1814-
infected cells showed reduced expression of ICP4, ICP0, and ICP8
compared with in1814R-infected cells (Fig. 1A), indicating that
VP16 is needed for optimal HSV immediate-early and early gene
expression in U2OS cells. When the n12 ICP4-null mutant was
compared with wild-type (WT) HSV-1, n12 virus-infected cells
showed virtually no ICP8 expression and enhanced ICP0 expres-
sion (Fig. 1B), indicating that ICP4 is essential for early HSV gene
expression in U2OS cells. Finally, the 7134 ICP0 mutant virus
showed normal levels of ICP8 expression in these cells (Fig. 1B),
consistent with previous reports that U2OS cells complement
HSV gene expression by other ICP0 mutant viruses (14). These
experiments suggested that cellular factors normally functioning
FIG 1 Viral factors required for IE and E gene expression in U2OS cells. (A)
U2OS cells were infected with in1814 VP16 mutant virus or in1814R rescued
virus at an MOI of 0.1 PFU/cell for 8 h, and ICP4, ICP8, and ICP0 expression
levels were detected by immunoblotting using specific antibodies. (B) U2OS
cells were either mock infected (0) or infected with wild-type (WT) KOS, n12
ICP4-null, 7134 ICP0-null, or 7134R rescued virus at an MOI of 0.1 for 14 h,
and ICP4, ICP8, and ICP0 expression levels were determined by immunoblot-
ting.
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with VP16 and ICP4 in other cells are likely involved in regulation
of HSV gene expression in U2OS cells.
Targeted chromatin factor RNAi and high-content imaging
screen. To identify U2OS cell-specific epigenetic factors, we per-
formed a targeted chromatin factor RNAi and high-content im-
aging screen using U2OS cells infected with a recombinant HSV,
HSV8GFP, which expresses the viral ICP8 protein fused to green
fluorescent protein (GFP). We measured GFP fluorescence in
HSV8GFP-infected cells to monitor viral gene expression, similar
to a previous small-molecule screen (28). To deplete host epige-
netic factors, we used an arrayed lentivirus-expressing short hair-
pin RNA (shRNA) library (The RNAi Consortium, Broad Insti-
tute) targeting 372 host chromatin-modifying factors for this
screen (see Table S1 in the supplemental material). This library
consists of 1,846 individual shRNAs targeting human genes
(shChromatin), with 4 or 5 unique shRNA sequences designed to
target the coding or 3= untranslated region sequence of each gene.
We also included shRNAs targeting GFP as a positive control
(shGFP) and shRNAs targeting RFP, luciferase, and lacZ as nega-
tive controls (shNegControl). For the screen, which is summa-
rized in Fig. 2, we seeded U2OS cells in 384-well plates and in-
fected them the next day with the lentivirus vectors expressing
shRNAs. Lentivirus-infected cells were selected in puromycin-
containing medium for 4 days and then infected with the reporter
virus HSV8GFP. At 2 days postinfection (dpi), the cells were fixed
and their DNA was stained with Hoechst dye to allow visualization
of all nuclei. We used a Cellomics automated high-content imag-
ing system to identify individual cells in each well by Hoechst
staining and then to measure the GFP intensity per nucleus. The
Cellomics software then calculated the average GFP intensity per
cell and the percentage of GFP-positive cells in each well.
To validate the screen, we first examined the distributions of
the average GFP intensity values and percent GFP-positive cells in
the shNegControl wells, the shGFP positive-control wells, and
shChromatin wells (see Fig. S1A in the supplemental material). As
expected, shGFP lentivirus-infected wells showed decreased aver-
age GFP intensity and percent GFP-positive cells relative to the
shChromatin-treated wells. In contrast, cells expressing shNeg-
Control showed no change in GFP expression (see Fig. S1A).
These results validated the ability of the screen to detect changes in
GFP expression due to shRNA activity.
We sought to identify genes with direct effects on viral gene
expression but not genes that produced indirect effects on the GFP
signals due to influence on host cell viability, proliferation, and/or
density. To this end, we calculated Z scores for the average GFP
intensity and percent GFP-positive cells. The Z scores were deter-
mined as (x  m)/SD, where x is the average GFP intensity or
percent GFP-positive cells for an individual shRNA, m is the av-
erage GFP intensity or percent GFP-positive cells for the complete
shChromatin data set, and SD is the standard deviation of its re-
spective m value (see Table S1 and Fig. S1B in the supplemental
material). We examined whether the per-cell average GFP inten-
sity or the percent GFP-positive cells was correlated to cell number
and found that neither of these metrics exhibited a strong depen-
dence on cell number (see Fig. S1B in the supplemental material).
We also evaluated the correlation ofZ scores between average GFP
intensity and percent GFP-positive cells (Fig. 3A). Linear regres-
sion analysis showed that the slope was 0.8705 0.01176 (Pearson
r 0.8632; P 0.0001), indicating a strong correlation between
the average GFP intensity and percent GFP-positive cells.
We then used the two Z scores, the number of shRNAs for the
specific gene that showed the effect, and the cell number per well
FIG 2 Schematic diagram of the shRNA and high-content imaging screen. U2OS cells were seeded in 384-well plates and incubated for 1 day at 37°C.
Lentiviruses expressing shRNAs were added to the U2OS cells, and puromycin was added the next day. Four days later, the cells were infected with HSV8GFP and
incubated for 2 days. The cells were fixed, nuclei were stained with Hoechst, and GFP fluorescence was measured with an automated Cellomics high-content
screening and analysis system.
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(the latter to compensate for toxic effects of shRNAs) to prioritize
the results from the screen. Strong hits were defined as those hav-
ing Z scores for average GFP intensity of 2 or 1.5 and Z
scores for percent GFP-positive cells of1 or1 for wells con-
taining more than 2,000 cells (Fig. 3B). Weak hits were also de-
fined as those having Z scores for both average GFP intensity and
percent GFP-positive cells of 1 (Fig. 3A, blue dotted box) or
1 (Fig. 3A, red dotted box) for wells containing more than
1,430 cells, which is approximately twice the SD of the complete
shChromatin set for negatively regulating or for positively regu-
lating hits, respectively. We applied a stricter cutoff to select strong
negatively regulating hits, because U2OS cells are known to be
more permissive than many other cell lines for HSV replication.
Table 1 shows the top hits with 2 or more shRNAs from strong hits
with positive or negative regulation effects and 3 or more shRNAs
from weak hits (Fig. 3A and B). These criteria resulted in 4 strong
and 7 weak positively regulating hits and 6 strong negatively reg-
ulating hits (Table 1).
Proteomic network and interactome analysis. We next per-
formed an interactome analysis to determine whether the epige-
netic factors identified in our screen were part of known func-
tional complexes. We first generated protein-protein interaction
maps by analyzing the selected hits in Table 1 in the GeneMANIA
human interactome database in Cytoscape (Fig. 4). We also inves-
tigated individual hits that did not generate protein-protein inter-
actions from the interactome analysis using UniProt, GeneCards,
and BioGRID protein and genetic databases to identify their bind-
ing partners and their functional properties. Several different
types of chromatin modifying complexes were identified (Fig. 4).
Chromatin remodeling complexes. Interestingly, 4 of the 11
positive regulators, PHF10, ARID1A, BAZ1B, and SMARCE1, are
members of SWI/SNF-type complexes (Fig. 4, top), which are
nucleosomal or chromatin-remodeling complexes. Notably, the
hSNF2H subunit of the ISWI chromatin remodeling complex that
was previously shown to promote HSV-1 replication in HEp-2
cells (11) was not one of the hits.
Histone demethylases. Two of the positive regulators identi-
fied were lysine demethylases, KDM3A and KDM6A (Table 1).
KDM3A removes dimethyl and monomethyl modifications from
histone H3 lysine 9 (H3K9me1/2) (23). Another lysine demethyl-
ase, KDM1A (LSD1), which has the same substrate specificity as
KDM3A and was previously shown to regulate HSV-1 gene ex-
pression (7), was not observed as a hit in our study, either because
it is not critical in U2OS cells or because the shRNAs did not
sufficiently reduce its expression levels to block HSV gene expres-
sion. KDM6A removes the trimethyl modification of histone H3
lysine 27 (H3K27me3) (29), which raises the possibility that
H3K27me3 is associated with lytic viral chromatin as well as latent
viral chromatin (30, 31).
Histone acetyltransferases. ING5 is a subunit of the H4-specific
acetyltransferase (HAT) HBO1 and the H3-specific MOZ/MORF
HAT complex (32). ING5 interacts with p300 and acetylates p53,
implying a tumor-related function (33). The CLOCK HAT, which
was shown to complement ICP0 mutant viruses in HEp-2 cells
(13), was not one of the hits in our screen.
Other positive regulators. METTL17 is a member of the
methyltransferase-like family. HDAC7 is a class II histone
deacetylase, and HOXD3 is a member of homeobox family of
highly conserved site-specific transcription factors. The prior
knowledge about these factors does not provide a specific mecha-
nism by which they might positively regulate HSV gene expres-
sion.
Histone deacetylase (HDAC) complexes. Of the genes with
negatively regulatory effects, three hits are part of HDAC com-
plexes as determined by proteomic network analysis (Fig. 4, bot-
tom). Sin3A and SUDS3 are core subunits in a histone deacetylase
(HDAC1/2) complex, and ING1 interacts with Sin3A (34). The
ING1-lamin A interaction is critical for cellular gene regulation
(35), and interestingly, depletion of lamin A/C increases viral het-
erochromatin and reduces HSV replication (36).
TBP-associated factors. Surprisingly, two of the down-
regulating factors, TAF1 and TAF3, were TBP-associated factors
FIG 3 Results from a targeted screen of chromatin factors. The average GFP
intensity and percent GFP-positive cells for each sample were analyzed to
determine the positively and negatively regulating hits. (A) Relationship be-
tween Z scores for average GFP intensity and percent GFP-positive cells. The
values for average GFP intensity and percent GFP-positive cells for the
shChromatin wells (gray dots) are shown. Selected positively regulating (in-
cluding weak hits,Z1) and negatively regulating (including weak hits,Z
1) hits from the shChromatin shRNAs are shown in red and blue dotted boxes,
respectively. (B) Distribution of Z scores. Red dots represent strong positively
regulating hits (Z  1.5), and green dots represent strong negatively regu-
lating hits (Z 2).
Oh et al.
4 ® mbio.asm.org January/February 2014 Volume 5 Issue 1 e01086-13
(TAFs) (Table 1; Fig. 4, bottom), usually thought to be transcrip-
tional activating factors. TAF1 and TAF3, previously shown to
bind to HSV-1 ICP4 in vitro and in mass spectrometry analysis
(37–39), may therefore play a role in ICP4’s negatively regulatory
properties.
Other negative regulators. ING1 was a negatively regulating
hit in our screen. Human ING1 proteins are known to differen-
tially regulate histone acetylation (40). Another negative regula-
tor, PDS5B, is a chromatin cohesion protein (41).
Validation of shRNA hits using siRNA-mediated knock-
down.To validate our primary screen hits, we depleted U2OS cells
of selected chromatin factors using double-stranded siRNA treat-
ment, and we then infected the cells with WT HSV-1 and mea-
sured viral gene expression using Western blot detection of the
viral ICP8 protein. We focused on 4 upregulating chromatin fac-
tor hits, KDM3A, KDM6A, ING5, and SMARCE1, and 4 down-
regulating hits, ING1, TAF3, SIN3A, and SUDS3, from our pri-
mary screen. When we transfected U2OS cells with ON-
TARGETplus SMARTpool siRNAs (Thermo-Fisher Scientific)
prior to HSV-1 infection, we observed that the siRNAs specific for
KDM3A, ING5, SMARCE1, TAF3, SIN3A, and SUDS3 reduced
the target protein levels efficiently (see Fig. S2A in the supplemen-
tal material). KDM6A and ING1 protein levels could not be eval-
uated by immunoblotting due to the lack of specific antibodies, so
we measured the transcript levels of these genes using quantitative
real-time PCR (Fig. 5A). The ING5 RNA level was reduced by 40
to 60%, and transcripts of the other genes were reduced by more
than 70% without any significant toxicity. To evaluate their effects
on viral gene expression, siRNA-transfected U2OS cells were in-
fected with wild-type HSV-1 strain KOS at a multiplicity of infec-
tion (MOI) of 0.1 PFU/cell and harvested at 0, 8, and 14 hpi.
siRNA knockdown of KDM3A, KDM6A, ING5, or SMARCE1
reduced ICP8 expression levels by 50% at 14 hpi (Fig. 5B; also, see
Fig. S2A in the supplemental material), which was consistent with
the positively regulatory effects observed in our primary screen.
Knockdown of SUDS3 increased ICP8 expression levels (1.5-fold;
P 0.0231), consistent with the negatively regulatory effects seen
TABLE 1 Top hits of epigenetic factors regulating HSV-1 in U2OS cells
Z score No. of shRNAs Gene Gene product description
Positively regulating genes
1.5 (strong) 2 HDAC7 Histone deacetylase 7A
HOXD3 Homeobox protein HoxD3
KDM6A Lysine (K)-specific demethylase 6A
PHF10 PHD finger protein 10
1 (weak) 4 METTL17 Methyltransferase-like 17
3 ARID1A AT-rich interactive domain 1A (SWI like)
BAZ1B Bromodomain adjacent to zinc finger domain, 1B
JMJD8 Jumonji domain containing 8
ING5 Inhibitor of growth family, member 5
KDM3A Lysine (K)-specific demethylase 3A
MARCE1 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin e1
Negatively regulating genes
2 (strong) 3 SUDS3 Sin3 histone deacetylase corepressor complex component SDS3
2 ING1 Growth inhibitor ING1/tumor suppressor ING1
PDS5B PDS5, regulator of cohesion maintenance, homolog B
SIN3A SIN3 homolog A, transcriptional regulator/transcriptional corepressor Sin3A
TAF1 TBP-associated factor 1, 250 kDa
TAF3 TAF3 RNA polymerase II, TATA box-binding protein (TBP)-associated factor,
140 kDa
FIG 4 Protein-protein interaction network maps for the major hits. Protein-
protein interaction networks of positively regulating (top) or negatively regu-
lating (bottom) hits were generated using GeneMANIA in Cytoscape. Extra 20
proteins (small circles and dots) that have known physical (blue lines) or
predicted (yellow lines) interactions with the input hits are shown to generate
the network maps.
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in the screen. Knockdown of TAF3 or SIN3A showed a trend to-
ward increased ICP8 expression, but the effects were not statisti-
cally significant (Fig. 5B; also, see Fig. S2 in the supplemental
material). Interestingly, knockdown of ING1 decreased the accu-
mulation of ICP8, the opposite of the primary screen phenotype.
Because we have not validated the knockdown of ING1 in our
primary screen, it was possible that this discrepancy could result
from the knockdown efficiency or shRNA-mediated effects in the
primary screen. In general, the siRNA knockdowns confirmed the
results of the primary shRNA-containing lentivirus-mediated
screen (Table 2).
Comparison of functional activity of KDM3A and KDM1A
(LSD1) in HeLa and U2OS cells. To study in more depth the role
of two apparently redundant enzymes in different cell lines, we
FIG 5 Validation of selected hits using siRNA-mediated knockdown followed by HSV-1 infection. (A) Depletion of chromatin factors using siRNAs. Nontarget
control (NT) and KDM3A-, ING5-, SMARCE1-, TAF3-, SIN3A-, and SUDS3-targeting siRNAs were transfected into U2OS cells, and transcript levels of the
indicated genes in siRNA-transfected cells were determined by qRT-PCR. (B) Effects of chromatin factor depletion on viral gene expression. U2OS cells were
infected at an MOI of 0.1 with WT HSV-1, and ICP8 expression levels were determined in cell extracts prepared at 14 hpi using immunoblotting. ICP8 levels were
quantified using ImageJ or Image Studio Lite (LI-COR). The ICP8 levels were normalized to GAPDH and the NT siRNA values. Values are from more than three
independent experiments, and values that are statistically significantly different from the NT value are indicated (*, P 0.05 [two-tailed paired t test]).
TABLE 2 Epigenetic factors regulating HSV-1 in different cell typesa
Cell type
Chromatin factor
Histone
modification Method Reference
Remodeling
factor HAT HDAC HMT HDM
HeLa HIRA RNAi 55
Asf1a RNAi 56
KMT2F
(SETD1A)
H3K4me3 RNAi 52
KMT7
(SETD7/9)
H3K4me1 RNAi 52
KDM1A
(LSD1)
H3K9me1/2 RNAi, inhibitor 7
KDM4A-D H3K9me3 RNAi, inhibitor 10
HepaRG ATRX-Daxxb ATRX-Daxxb RNAi 25
CV-1 Asf1b RNAi 57
Sensory neuron REST H3Kac dnREST 45
U251-MG CoREST-REST H3Kac RNAi 53
MRC5 KDM4A-D H3K9me3 RNAi, inhibitor 10
HFF KDM1A
(LSD1)
H3K9me1/2 Inhibitor 10
KDM4A-D H3K9me3 Inhibitor 10
HEp-2 SMARCA5
(SNF2H)
RNAi 11
CLOCK H3, H4Kac RNAi 58
U2OS SMARCE1 RNAi This study
TAF3 RNAi This study
ING5 H3, H4Kac RNAi This study
ING1b ING1b H3, H4Kac RNAi This study
SIN3A-SUDS3 H3, H4Kac RNAi This study
KDM6A H3K27me2/3 RNAi This study
KDM3A H3K9me1/2 RNAi This study
a Abbreviations: HAT, histone acetyltransferase; HDAC, histone deacetylase; HMT, histone methyltransferase; HDM, histone demethylase.
b Not classified.
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then focused on the utilization of KDM1A (LSD1) and KDM3A in
two different cell lines, HeLa and U2OS cells. KDM3A and
KDM1A (LSD1) both target H3K9me1/2 for demethylation (42);
however, it is not clear how the activity of these functionally re-
dundant methylases is regulated in different cell types. KDM1A
(LSD1) promotes euchromatin on and expression of IE genes in
HeLa and HFF cell lines (7, 10) but did not show a significant
effect on ICP8 expression in our primary screen. However, deple-
tion of KDM3A resulted in decreased HSV-1 gene expression in
U2OS cells (Fig. 5B).
To compare the functionality of KDM1A (LSD1) and KDM3A
in the different cell lines, we depleted KDM1A or KDM3A in HeLa
or U2OS cells using siRNAs (Fig. 6, left), infected the cells with
WT HSV-1, and measured IE ICP4 expression by Western blot-
ting (Fig. 6, right). First, these blots showed approximately equal
levels of KDM1A (LSD1) in HeLa and U2OS cells and approxi-
mately equal levels of KDM3A in HeLa and U2OS cells (Fig. 6,
left). Second, depletion of KDM1A (LSD1) in HeLa cells reduced
the ICP4 level by about 45% (P 0.01) compared to that in cells
transfected with nontargeting siRNAs (Fig. 6, right). In contrast,
depletion of KDM3A in HeLa cells showed only a 10 to 15% re-
duction. Depletion of KDM1A (LSD1) in U2OS cells did not cause
a statistically significant decrease in ICP4 expression, but deple-
tion of KDM3A did cause a statistically significant decrease in
ICP4 expression in U2OS cells (Fig. 6, right). These results are
consistent with the idea that KDM1A (LSD1) is more essential in
HeLa cells while KDM3A is equally or more critical in U2OS cells.
To confirm the apparent cell type-specific functionality of
KDM1A (LSD1) using a different approach, we tested the effect of
the monoamine oxidase inhibitors (MAOIs), tranylcypromine
(TCP) and pargyline, which are known KDM1A (LSD1)-specific
inhibitors (7), on HSV gene expression in HeLa and U2OS cells.
Treatment of HeLa cells with TCP reduced ICP4 expression in
HeLa cells (Fig. 7A; also, see Fig. S3 in the supplemental material),
which was consistent with previous reports (7, 10), but TCP treat-
ment had no effect on ICP4 expression in U2OS cells. Pargyline
treatment of HeLa cells similarly reduced ICP4 expression in HeLa
cells (Fig. 7B; also, see Fig. S3 in the supplemental material) but led
to an increase in ICP4 expression in U2OS cells. Similar to the
protein levels, TCP treatment reduced ICP4 transcripts in HeLa
cells (Fig. 7C; also, see Fig. S3) but led to increased levels of ICP4
transcripts in U2OS cells. Similar effects were observed with ICP8
RNA levels in HeLa and U2OS cells (Fig. 7D). These results con-
firmed that KDM1A (LSD1) is more critical for HSV gene expres-
sion in HeLa cells than in U2OS cells.
DISCUSSION
HSV-1, like other nuclear DNA viruses (43), is subject to and
manipulates the host cell epigenetic pathways to promote its own
gene expression during lytic infection. The viral VP16 and ICP0
proteins have been shown to combat host-cell silencing mecha-
nisms in normal human cells (3, 5, 12). The dependence on VP16
and ICP0 differs in different cell types (14, 15, 24), suggesting that
the host epigenetic factors that are functional in these different cell
types may differ. We tested this hypothesis by conducting a screen
to identify the epigenetic factors that regulate HSV gene expres-
sion in U2OS osteosarcoma cells, which complement ICP0 mu-
tant virus replication. We found that the specific epigenetic factors
that regulate HSV-1 gene expression in U2OS cells are different
from those previously shown to be critical in other cell types.
Furthermore, HSV-1 gene expression was differentially sensitive
to a drug that inhibits a specific histone demethylase in U2OS cells
compared with HeLa cells. There appeared to be equivalent levels
of KDM1A (LSD1) and KDM3A proteins expressed in U2OS and
HeLa cells, indicating that there are different activities of these
enzymes in the cells. These results demonstrate the need to probe
the functionality of epigenetic factors rather than just their levels
of expression. Furthermore, these results argue that although HSV
can replicate in many cell types, different epigenetic mechanisms
may be important for facilitating viral gene expression and repli-
cation in these cells.
Classes of chromatin modifiers and HSV-1 replication.
HSV-1 gene expression has been shown to be regulated by several
classes of host chromatin modifiers, including histone demethy-
lases (e.g., KDM1A [LSD1]) (7, 10), histone methyltransferases
(e.g., KMT2F [SETD1A]) (44), histone deacetylases (e.g., CoREST
complexes with HDAC1) (45), and chromatin-remodeling factors
(e.g., hSNF2H) (11). In this screen we identified the same general
classes of chromatin modifiers in U2OS cells, but the specific
chromatin factors were different.
Histone demethylases. Previous studies had found that the
KDM1A (LSD1) and KDM4 (JMJD2) demethylases are required
FIG 6 Comparison of HSV gene expression following depletion of KDM1A or KDM3A in HeLa and U2OS cells. (Left) KDM1A- or KDM3A-specific
siRNA-transfected HeLa and U2OS cells were infected with WT HSV-1 at an MOI of 0.1, and ICP4 expression levels were determined by immunoblotting.
(Right) ICP4 expression level was quantified using Image Studio (LI-COR) and normalized to the GAPDH value. Normal and depleted levels of KDM1A and
KDM3A in each cell type were determined by immunoblotting using specific antibodies. Values are from more than three independent experiments, and
comparisons that are statistically significant are indicated (*, P 0.05; **, P 0.01 [two-tailed paired t test]).
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for HSV-1 IE gene expression in HeLa cells and human fibroblasts
(7, 10), with KDM4 demethylating HeK9me3 and KDM1A LSD1
demethylating H3K9me1/2. In our screen, we found that KDM3A
was required for HSV gene expression in U2OS cells. KDM3A has
the same substrate specificity as KDM1A (LSD1) (42). Therefore,
this result highlights the requirement for one or the other of these
demethylase activities and strengthens the idea of the necessity of
demethylation of H3K9 for expression of HSV-1 gene expression,
although U2OS and HeLa cells likely differ in the KDMs used.
KDM1A (LSD1) is recruited by HCF-1 to the HSV genome for this
function, but we do not know if KDM3A is recruited to the HSV
genome or if KDM3A is responsible for directly regulating HSV
gene expression.
We found that KDM6A (UTX) is required for HSV-1 gene
expression, presumably to remove the H3K27me2/3 heterochro-
matic marks from the viral chromatin. Although H3K27me3 het-
erochromatic marks have been found on latent HSV-1 genomes
(30, 31, 46), there is no published evidence that this histone mod-
ification occurs during lytic infection. Recent studies in our labo-
ratory have shown a transient H3K27 trimethylation of viral chro-
matin during HSV-1 infection of normal human fibroblasts
(P. Raja, J. S. Lee, and D. M. Knipe, unpublished results). Further
studies are needed to determine whether there is a direct role for
KDM6A in HSV gene expression.
Histone acetyltransferases. Previous studies had shown the
involvement of the CLOCK HAT (Table 2), which was shown to
complement ICP0 mutant viruses in HEp-2 cells (13). The
CLOCK HAT was not one of the hits in our screen, but in our
studies we found that the ING5 and ING1 acetyltransferases are
necessary for HSV-1 gene expression in U2OS cells. ING5 is a
component of both the histone H4-specific acetyltransferase
HBO1 and the histone H3-specific acetyltransferase MOZ/MORF
complexes (32). However, we did not observe a significant effect
on GFP signal following depletion of ING5-associated HATs
(KAT6A, KAT7, and KAT8; KAT6B was not tested) in our screen.
This might be due to inefficient knockdowns, a requirement for all
or more than one to be knocked down together, or a role for ING5
in other complexes. Depletion of ING1 showed reduced ICP8 ex-
pression in our validation, which was opposite to the results from
our primary screen. It should be noted that ING1 expresses five
isoforms and two of them, p33ING1b and p47ING1a, are shown
to be functionally opposite. p33ING1b binds to CBP-p300 (HAT)
and mSin3-HDAC1/2 and p47ING1a binds the mSin3-HDAC1/2
complex (34, 40, 47, 48). Although p33ING1b also interacts with
the Sin3 repressor complex, overexpression of p33ING1b in-
creases acetylation of histones H3 and H4, and conversely, over-
expression of p47ING1a enhances deacetylation (40, 47–49).
Therefore, the possibility of isoform-dependent effects needs to be
further evaluated to clarify our results.
Histone deacetylases. Previous studies have shown that
HDAC1 complexes with CoREST and REST (50, 51), and these
complexes are disrupted and inactivated by HSV-1 ICP0, which
FIG 7 HSV gene expression in the presence of KDM1A (LSD1) inhibitors in U2OS and HeLa cells. (A) Effects of TCP on viral gene expression in HeLa and U2OS
cells. HeLa and U2OS cells were pretreated with the indicated concentrations of TCP for 4 h, infected at an MOI of 0.1, and harvested at 4 hpi. The same
concentrations of TCP were maintained until the cells were harvested. ICP4 expression was quantified relative to GAPDH. (B) Effects of pargyline on viral gene
expression in HeLa and U2OS cells. HeLa and U2OS cells were pretreated with the indicated concentrations of pargyline for 4 h, infected at an MOI of 0.1 and
harvested at 4 hpi. The same concentrations of pargyline were maintained until the cells were harvested. ICP4 expression was quantified relative to GAPDH. (C
and D) Effects of TCP on viral RNA expression. ICP4 (C) and ICP8 (D) transcript levels were quantified using qPCR at 4 hpi under the conditions described
above. Values that are statistically significantly different at the same concentration of TCP treatment are indicated (*, P  0.05; **, P  0.01; ***, P  0.001;
two-way analysis of variance [ANOVA] with Bonferroni posttest).
Oh et al.
8 ® mbio.asm.org January/February 2014 Volume 5 Issue 1 e01086-13
promotes HSV-1 gene expression (12). In this study, we found
that the SIN3A-SUDS3-HDAC complex plays a role in repression
of ICP8 expression in U2OS cells.
Chromatin-remodeling enzymes. A previous study from our
lab had shown a requirement for the hSNF2H chromatin-
remodeling complex subunit for efficient HSV-1 IE gene expres-
sion, and in particular for ICP0 gene transcription, in human
HEp-2 cells (11). In this study, we found a requirement for the
SMARCE1 protein in U2OS cells. Therefore, a different
chromatin-remodeling complex appears to be functional in these
cells.
In total, our results show a different set of chromatin-
modifying factors that are operative in U2OS osteosarcoma cells
compared with cells previously studied. This study shows the
power of an HSV-1 infection screen in the identification of the
critical factors in these classes of chromatin remodelers. This sys-
tem could be used to determine the chromatin factors that are
functional in cells from cancer and other disease states.
Support for the idea of epigenetic regulation of HSV-1 gene
expression. We observed that U2OS cells have the same major
classes of epigenetic factors regulating HSV-1 gene expression as
other cell types but that the specific members of these classes dif-
fer. This supports the general concept of epigenetic regulation of
HSV gene expression during lytic infection (3) in which cellular
functions attempt to silence viral genes and viral gene products
recruit other cellular epigenetic factors to reverse and/or negate
the host silencing response.
The mechanistic basis for the differential activity of KDM1A
and KDM3A in HeLa versus U2OS cells remains to be defined.
The two enzymes appear to be expressed at similar levels in the two
cell lines, so a difference in expression levels is not the explanation.
The enzymes may be mutationally altered in the different cells, or
their activities may be regulated differently by other gene prod-
ucts. Further studies are needed to explain these differences.
Epigenetic drugs and HSV-1 replication. Consistent with the
essential role of host epigenetic factors in HSV-1 gene expression
and replication, pharmacological inhibition of the KMT2F
(SETD1A) methyltransferase (52) or KDM1A (LSD1) and KDM4
(JMJD2) demethylases reduce IE gene expression, productive in-
fection, and reactivation (7, 10). A key observation in this field was
that the KDM1A (LSD1) inhibitors TCP and pargyline (7) inhibit
IE gene expression of HSV in HeLa cells and in explant reactiva-
tion of latent HSV-1 (7). In this study, we also found that MAOI
treatment reduced HSV gene expression in HeLa cells. However,
MAOI treatment did not reduce IE gene expression in U2OS cells,
supporting the hypothesis that different epigenetic factors are re-
quired to promote HSV-1 gene expression in the different cell
lines. Surprisingly, the ICP4 and ICP8 RNA levels increased in
U2OS cells as the MAOI concentrations increased. Depending on
the specific proteins associated with it, KDM1A (LSD1) can play a
role as an activator or repressor (7, 53), and it is possible that
KDM1A (LSD1) has higher repressive activity than activating ac-
tivity for HSV gene expression in U2OS cells directly and/or indi-
rectly. This is of interest because KDM1A (LSD1) has been shown
to be overexpressed in osteosarcoma tumor cells (54), and those
investigators suggested that KDM1A (LSD1) is an epigenetic drug
target in these cells. It is possible that in vivo conditions change the
requirements for these HDMs. Further studies are needed to test
the role of KDM1A in different cell types. In any event, our MAOI
results obtained with U2OS cells were consistent with the screen
results showing a reduced KDM1A (LSD1) activator effect in this
cell type. Functional studies like HSV-1 infection should be em-
ployed to show that KDM1A (LSD1) is truly functional in these
cells and participates in a rate-limiting step in epigenetic regula-
tion to justify the use of these drugs for these cancers.
HSVinfectionas anepigenetic screen.Our results suggest that
HSV-1 infection can be used as a screen for the chromatin-
modifying factors that are critical within a specific cell line or cell
type. This could have two applications. First, an HSV infection
epigenetic screen could test tumor cells or cells from other disease
states to define the specific chromatin factors that are functional
with these cells and thereby identify potential targets for chemo-
therapy in various disease states, including cancer. Second, an
HSV infection screen may also provide an assay for the efficacy of
epigenetic drugs in specific cell types as antiviral treatments for
HSV, as has been proposed by others (7).
MATERIALS AND METHODS
Cells, viruses, and drug treatments. HeLa, U2OS, and Vero cells were
obtained from the American Type Culture Collection (Manassas, VA).
HSV8GFP was constructed in the HSV-1 KOS genetic background (8GFP
is in the HSV-1 KOS1.1 genetic background). The HSV-1 KOS wild-type
strain, the 7134 ICP0-null virus, 7134R rescued virus, the ICP4-null n12
virus, the in1814 VP16 insertion mutant, and in1814R rescued viruses
were grown and used. See the supplemental material for more details.
For drug treatment experiments, the cells were pretreated with drugs
at various concentrations for 4 h and infected with virus at the concentra-
tions described above, and the medium was changed to Dulbecco’s mod-
ified Eagle medium (DMEM)–1% calf serum containing the same con-
centration of the appropriate drug.
shRNA and high-content imaging screen. U2OS cells (450/well)
seeded in 384-well plates were infected with lentivirus vectors (1.5 l/
well). After 1 day, lentivirus-infected cells were selected using puromycin
(1 g/ml; catalog no. P8833; Sigma-Aldrich) for 4 days followed by
HSV8GFP infection (2.5  105 PFU/well). After 2 days, the cells were
fixed, stained with Hoechst 33342 (catalog no. H3570; Invitrogen). The
average GFP intensity per cell and the percent GFP-positive cells in each
well were calculated as described in the supplemental material.
Interactome analysis. We generated functionally enriched protein-
protein interaction networks for the up- and down-regulating hits in Ta-
ble 1 using GeneMANIA (http://genemania.org/) in Cytoscape (http:
//www.cytoscape.org/). See the supplemental material for more details.
siRNA depletion of specific gene products. For the validation of the
primary screen hits, we used ON-TARGETplus SMARTpool siRNAs
(Thermo Fisher Scientific) to knock down expression of specific gene
products. See the supplemental material for more details.
SDS-PAGE and immunoblotting. For details about the procedures
used for SDS-PAGE and immunoblotting, see the supplemental material.
Quantification of RNA levels using reverse transcription and real-
time PCR. DNase I-treated total RNA (0.5 g) was reverse transcribed
and quantified by real-time PCR. RNA levels were normalized to that of
18S rRNA to adjust for recovery. See the supplemental material for more
details.
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